These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 37838339)

  • 21. Skin sympathetic nerve activity precedes the onset and termination of paroxysmal atrial tachycardia and fibrillation.
    Uradu A; Wan J; Doytchinova A; Wright KC; Lin AYT; Chen LS; Shen C; Lin SF; Everett TH; Chen PS
    Heart Rhythm; 2017 Jul; 14(7):964-971. PubMed ID: 28347833
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Meta-analysis of high power short duration in atrial fibrillation ablation - a superior efficient ablation strategy.
    Xu M; Yang Y; Zhang D; Jiang W
    Acta Cardiol; 2022 Feb; 77(1):14-32. PubMed ID: 34218737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Empirical superior vena cava isolation in patients undergoing repeat catheter ablation procedure after recurrence of atrial fibrillation.
    Simu G; Deneke T; Ene E; Nentwich K; Berkovitz A; Sonne K; Halbfass P; Arvaniti E; Waechter C; Müller J
    J Interv Card Electrophysiol; 2022 Nov; 65(2):551-558. PubMed ID: 35857220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-power, short-duration atrial fibrillation ablations using contact force sensing catheters: Outcomes and predictors of success including posterior wall isolation.
    Winkle RA; Mead RH; Engel G; Kong MH; Salcedo J; Brodt CR; Patrawala RA
    Heart Rhythm; 2020 Aug; 17(8):1223-1231. PubMed ID: 32272229
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and outcome of very high-power short-duration ablation using 70 W for pulmonary vein isolation in patients with paroxysmal atrial fibrillation.
    Kottmaier M; Popa M; Bourier F; Reents T; Cifuentes J; Semmler V; Telishevska M; Otgonbayar U; Koch-Büttner K; Lennerz C; Bartkowiak M; Kornmayer M; Rousseva E; Brkic A; Grebmer C; Kolb C; Hessling G; Deisenhofer I
    Europace; 2020 Mar; 22(3):388-393. PubMed ID: 31872249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations of sympathetic dynamics after atrial fibrillation ablation by analysis sympathetic nerve activity provide prognostic value for recurrence and mechanistic insights into ablation.
    Chen JJ; Lin C; Chuang YC; Lee SF; Lin TY; Yu CC; Tsai CT; Liao MT; Lin TT; Lin LY; Lo MT
    Front Cardiovasc Med; 2022; 9():1024156. PubMed ID: 36531709
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Colchicine usage for prevention of post atrial fibrillation ablation pericarditis in patients undergoing high-power short-duration ablation.
    Iqbal AM; Li KY; Gautam S
    J Cardiovasc Electrophysiol; 2023 Jun; 34(6):1370-1376. PubMed ID: 37232420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Update on high-power short-duration ablation for pulmonary vein isolation.
    Qiu J; Wang Y; Wang DW; Hu M; Chen G
    J Cardiovasc Electrophysiol; 2020 Sep; 31(9):2499-2508. PubMed ID: 32621311
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of outcomes with low-power long duration versus high-power short duration of ablation: the role of the acute change in sinus rhythm after the ablation as a predictor of long-term success.
    Vassallo F; Meigre LL; Cunha C; Serpa E; Simoes A; Lovatto C; Gasparini D; Corcino L; Schmidt A
    Heart Vessels; 2022 Oct; 37(10):1749-1756. PubMed ID: 35430635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of pulmonary vein isolation using cryoballoon, high-power short-duration, and conventional radiofrequency ablation for atrial fibrillation: a propensity score-weighted study.
    Park H; Park JW; Kim D; Yu HT; Kim TH; Uhm JS; Joung B; Lee MH; Hwang C; Pak HN
    Front Cardiovasc Med; 2023; 10():1238363. PubMed ID: 37876772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical outcome of lesion size index-guided high-power radiofrequency catheter ablation for pulmonary vein isolation in patients with atrial fibrillation: 2-year follow-up.
    Cai C; Wang J; Niu HX; Chu JM; Hua W; Zhang S; Yao Y
    J Cardiovasc Electrophysiol; 2023 Mar; 34(3):546-555. PubMed ID: 36640429
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute oesophageal safety of high-power short duration with 50 W for atrial fibrillation ablation.
    Müller J; Berkovitz A; Halbfass P; Nentwich K; Ene E; Sonne K; Simu G; Chakarov I; Barth S; Waechter C; Behnes M; Akin I; Deneke T
    Europace; 2022 Jul; 24(6):928-937. PubMed ID: 35134155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High-power short-duration versus low-power long-duration ablation for pulmonary vein isolation: A substudy of the AWARE randomized controlled trial.
    Joza J; Nair GM; Birnie DH; Nery PB; Redpath CJ; Sarrazin JF; Champagne J; Bernick J; Wells GA; Essebag V;
    J Cardiovasc Electrophysiol; 2024 Jan; 35(1):136-145. PubMed ID: 37990448
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Incidence of ablation-induced esophageal injury associated with high-power short duration temperature-controlled pulmonary vein isolation using a specialized open-irrigated ablation catheter: A retrospective single-center study.
    Piringer R; Deneke T; Foldyna B; Sonne K; Nentwich K; Ene E; Barth S; Lüsebrink U; Berkovitz A; Halbfass P
    J Cardiovasc Electrophysiol; 2021 Mar; 32(3):695-703. PubMed ID: 33442930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. HPSD ablation for AF high-power short-duration RF ablation for atrial fibrillation: A review.
    Winkle RA
    J Cardiovasc Electrophysiol; 2021 Oct; 32(10):2813-2823. PubMed ID: 33382506
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 50-W vs 40-W During High-Power Short-Duration Ablation for Paroxysmal Atrial Fibrillation: A Multicenter Prospective Study.
    Costea A; Diaz JC; Osorio J; Matos CD; Hoyos C; Goyal S; Te C; D'Souza B; Rastogi M; Lopez-Cabanillas N; Ibanez LC; Thorne C; Varley AL; Zei PC; Sauer WH; Romero JE
    JACC Clin Electrophysiol; 2023 Dec; 9(12):2573-2583. PubMed ID: 37804258
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary vein isolation for atrial fibrillation using true high-power short-duration vs. cryoballoon ablation.
    Wörmann J; Lüker J; van den Bruck JH; Filipovic K; Erlhöfer S; Scheurlen C; Dittrich S; Schipper JH; Steven D; Sultan A
    Clin Res Cardiol; 2023 Jun; 112(6):846-852. PubMed ID: 37009942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Reconnection patterns after CLOSE-guided 50 W high-power-short-duration circumferential pulmonary vein isolation and substrate modification-PV reconnection might no longer be an issue.
    Francke A; Scharfe F; Schoen S; Wunderlich C; Christoph M
    J Cardiovasc Electrophysiol; 2022 Jun; 33(6):1136-1145. PubMed ID: 35118734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety aspects of very high power very short duration atrial fibrillation ablation using a modified radiofrequency RF-generator: Single-center experience.
    Mueller J; Halbfass P; Sonne K; Nentwich K; Ene E; Berkovitz A; Lehmkuhl L; Barth S; Simu GR; Waechter C; Behnes M; Deneke T
    J Cardiovasc Electrophysiol; 2022 May; 33(5):920-927. PubMed ID: 35233883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low-energy (360 J) radiofrequency catheter ablation using moderate power - short duration: proof of concept based on in silico modeling.
    Pérez JJ; D'Angelo R; González-Suárez A; Nakagawa H; Berjano E; d'Avila A
    J Interv Card Electrophysiol; 2023 Aug; 66(5):1085-1093. PubMed ID: 35796934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.